<html>
<head>PUBMED IDs for LRRC59</head>
<body bgcolor='#C5F0F2'><h1>LRRC59</h1><a href='https://pubmed.ncbi.nlm.nih.gov/25238935/'>Novel fusion transcripts associate with progressive prostate cancer.</a> May 3  2014<br><a href='https://pubmed.ncbi.nlm.nih.gov/25238925/'>Gene mutations and stroke in the young adult.</a> November 18  2014<br><a href='https://pubmed.ncbi.nlm.nih.gov/25238906/'>[Niemann-Pick type C disease and psychosis: Two siblings].</a> March 5  2014<br><a href='https://pubmed.ncbi.nlm.nih.gov/25736928/'>Cancerous inhibitor of protein phosphatase 2A promotes premature chromosome segregation and aneuploidy in prostate cancer cells through association with shugoshin.</a> November 17  2015<br><a href='https://pubmed.ncbi.nlm.nih.gov/25833693/'>Leucine-rich repeat-containing protein 59 mediates nuclear import of cancerous inhibitor of PP2A in prostate cancer cells.</a> November 17  2015<br><a href='https://pubmed.ncbi.nlm.nih.gov/26527623/'>Translating Proteomic Into Functional Data: An High Mobility Group A1 (HMGA1) Proteomic Signature Has Prognostic Value in Breast Cancer.</a> October 12  2015<br></body></html>
